The IPO Roadmap: How RLX Deployment Worked

RLX went public at a listing price of HK$8.94 per Class B ordinary share, raising approximately HK$5.92 billion (USD 756 million) in one of the largest tech IPOs on the Hong Kong exchange that year. The allocation split favoured institutional anchor investors — including Temasek Holdings, which committed HK$300 million at the offering price.

1. Pre-IPO restructuring (Q4 2025). RLX reorganised its Chinese domestic operations under a VIE structure to satisfy Hong Kong SFC requirements on principal-activity sourcing and overseas listing compliance.
2. Marketing spend spike. In the six months preceding listing, the company spent RMB $680 million on digital campaigns featuring popular KOLs across Douyin, Bilibili, Xiaohongshu, and YouTube — building brand awareness that would translate directly into distributor pipeline conversations in new territories.
3. Lock-up management. RLX structured its prospectus with staggered lock-up periods: six months for founders and Series-C investors, twelve months for venture capital limited partnerships. This design ensured share-price stability while still providing early return liquidity.

Supply Chain Dominance: The Shenzhen Advantage, Revisited

Perhaps the most underappreciated element of RLX’s strategy is its vertically integrated manufacturing footprint. The company owns or controls nine production facilities in Guangdong and Zhejiang provinces, covering everything from atomizer coil winding to e-liquid flavor-blending. By 2026, these plants were producing over 420 million disposable units annually.—approximately one-quarter of all vapor devices sold worldwide that year.

This concentration creates a flywheel: more orders from RLX’s global distributor network justify larger capacity expansions; larger factories lower per-unit costs; lower costs reinforce pricing power in overseas bidding. No competitor outside China has achieved similar scale elasticity.

New Markets, New Regulations — What RLX Tackled in 2026

The company’s post-IPO market-entry pipeline for Q1-Q2 2026 covers a diverse set of regulatory environments. Each required different product-logging timelines, nicotine-cap adjustments, and sometimes tamper-evident packaging mandates.

Competitor Moves: STX, Geek Bar, and the Race for Margin Space

RLX’s IPO spotlight has forced competitors to recalibrate. STX Aviation Group, which listed on NASDAQ in February 2025 at a $38 valuation that has since halved to ~$19, is pursuing an acquisition-led growth plan — buying smaller European distributors to reach €500M revenue by end of FY26.

Shenzhen Geek Network Limited, operator of the Geek Bar consumer brand (itself the third-largest disposable seller in North America), is negotiating a potential dual listing on both Hong Kong and Singapore exchanges, modelling its IPO prospectus closely on RLX’s chapter-by-chapter disclosures.

The competitive dynamic matters for supply-chain partners and ingredient manufacturers: as leading brands compete on scale rather than margin, contract混配 (OEM) e-liquid formulators in Dongguan and Foshan are seeing their order books fill through 2027 — but the per-litre price paid by vape brands has been deflating at roughly 3-5% annually.

What This Means for Smaller Vape Brands in China

The rise of RLX as a public titan does not doom smaller manufacturers. On the contrary, new entrants have more pathways today than ever:

1. OEM/ODM partnerships. Companies lacking manufacturing depth can now lease capacity at RLX-owned or contracted factories during off-peak seasons, accessing production quality previously achievable only with multi-million-dollar CAPEX. This model already accounts for approximately 28% of orders from non-RLX brands entering the EU and UK.
2. Niche flavor innovation.

RLX’s core portfolio focuses on mainstream nicotine-salt disposables (4500 puff, pre-mixed fruit/tobacco flavors). Brands specialising in low-nicotine botanicals (<20mg/ml), heat-not-burn alternatives using natural extracts, or refillable pod systems with refill-pod subscription models carve profitable niches the mass-market players undervalue.

3. Premium packaging positioning.

   In Japan and South Korea, where duty on premium devices under ¥500 per unit is significantly lower, boutique Japanese brands using ceramic coils, hand-finished aluminum bodies, and seasonal limited-edition colourways are commanding retail prices ¥2-3x the RLX equivalent per device. This margin premium offsets smaller volumes.

Risks on the Horizon: Regulatory Fragility & Geopolitics

No analysis of post-IPO vape growth is complete without acknowledging structural risks:

• US FDA enforcement cycle.

If the US Office of Compliance accelerates de novo review rejections for nicotine-salt devices above 5%, RLX could be forced to reformulate its entire disposables pipeline (~RMB 4.2 billion in FY25 export revenue to North America).

• Cross-strait tensions.

A military or economic disruption affecting Shenzhen-to-Singapore shipping lanes within the next 12 months would temporarily raise logistics costs by an estimated 18-22%, squeezing margins for all mainland-manufactured vape brands.

• Commodity nicotine pricing. Global pharmaceutical-grade nicotine supply tightened in Q1 2026 as India’s major producers (Flavordrome, NicChem) shifted capacity toward generic prescription e-cigarettes, leaving vape-grade supply to compete for reduced volumes. Spot prices rose +13% year-to-date.

Investor Outlook: Can RLX Defend Its Premium Valuation?

At current levels (HK$12.70, market cap ~HK$86 billion), RLX trades at approximately 34x FY25 adjusted earnings — a significant premium versus STX Aviation at ~18x and global e-cigarette leaders like Altria’s NJOY brand at ~22x forward multiple. The question is whether this premium is justified.

Actionable Takeaways for Vape Industry Stakeholders

Whether you run a Shenzhen OEM factory, a UK-based vape distributor, or an e-liquid raw-material supplier, here are five concrete actions to consider in the next quarter:

1. Evaluate duty-bracket alignment

.

If you export refills or pre-fills to any EU market (or are planning a UK entry), ensure your highest-selling SKU lands just below the £25/L vaping duty threshold — currently proposed for Ireland and Denmark by late 2026. A product at 15mg/mL nicotine offers similar consumer satisfaction while incurring ~$3-4 less duty per thousand units than a 20mg/mL alternative.

2. Diversify contract manufacturing beyond Guangdong

. Malaysian and Thai facilities are scaling vaping-specific lines for 2026 Q3-Q4 entry, benefiting from bilateral free-trade agreements with China and ASEAN. A dual-plant strategy reduces geopolitical exposure to cross-strait logistics disruption.

3. Monitor RLX lock-up calendar

. With ~18% of outstanding shares still under lock-up through June 2026 and further tranche unlocks in January 2027, any secondary issuance or major anchor investor sale could trigger short-term price pressure — creating opportunities for institutional accumulators.

4. Prioritise low-nicotine R&D

. If the FDA maintains or tightens its 5% cap on free-base nicotine and moves similarly on nicotine-salt maximum concentration, RLX’s heavy-disposables portfolio faces headwinds. Brands with <20mg/ml refillable pods ready can pivot first.

5. Explore subscription models

. In markets with higher disposable taxes (UK, Ireland, Netherlands), recurring pod-refill subscriptions reduce the consumer perception of per-unit price and increase LTV — RLX’s UK distributor already piloting a “Cloud Club” membership at £12/month for four 10ml refill pods delivered quarterly.